Journal profile · Oncology
Oncologie
ISSN 1292-3818 · eISSN 1765-2839 · Tech Science Press · FRANCE · Bimonthly · Founded 2004
Oncologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.13; fully open access; APC charged, amount not published; review 6–12 weeks (community reports); community-reported acceptance: easy; 98 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Oncologie is published by Tech Science Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health, Medicine and Society, Healthcare Systems and Practices and Cancer Treatment and Pharmacology, together about 28.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
About this journal Oncologie is aimed at publishing high-quality original research articles and review papers with a focus on in vivo or in vitro studies of cancer biology and clinical research. It welcomes studies related to the pathology, prevention and diagnosis, and advanced treatment of all types of cancers, as well as research from any of the disciplines related to these fields of interest.The journal is owned by Tech Science Press.Oncologie is an open access journal. It has French and English publications, currently publishes English-language articles mainly. The publication frequency is bimonthly.Aims & ScopeOncologie publishes original research, reviews, case reports, and other contributions across all aspects of tumor and cancer research and treatment, including molecular and cellular oncology, cancer prevention, early detection and screening, diagnosis, and clinical management of neoplastic diseases.The journal welcomes both clinical and preclinical studies, including clinical trials, pharmacology, molecular alterations, and biomarkers predicting treatment response or resistance, as well as in vitro and in vivo studies of tumor biology, progression, metastasis, and therapy resistance. Research in precision oncology, personalized medicine, and molecular oncology is particularly encouraged, with an emphasis on translational research bridging laboratory discoveries with clinical applications.Research topics may include, but are not limited to: Cancer genetics and genomicsOmics and bioinformatics in cancer researchCancer cytology and pathologyImmunology, immuno-oncology, and immunotherapyChemotherapy and radiotherapyPrecision oncology and personalized medicineSolid tumors and surgical oncologyGynecologic and hematologic oncologyPediatric oncologyPalliative and supportive care, survivorship, and quality-of-life researchOncology nursing and psycho-oncologyClinical trial designCancer epidemiologyMethodological studies, including modern statistical approaches and meta-analyses History Former publication of Oncologie(2004-2017): https://link.springer.com/journal/10269/volumes-and-issues(2018-2019): https://onco.revuesonline.com/component/issues(2019-2022): https://www.techscience.com/journal/oncologie
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Lei ZhengPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health, Medicine and SocietyHealth Professions11.1%
- Healthcare Systems and PracticesHealth Professions9%
- Cancer Treatment and PharmacologyMedicine8.4%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.1%
- Colorectal Cancer Treatments and StudiesMedicine4.6%
- Lung Cancer Treatments and MutationsMedicine4.4%
- Multiple and Secondary Primary CancersMedicine4.1%
- Cancer Immunotherapy and BiomarkersMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ProQuest, OCLCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.13LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- 5-year impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher)
- 3.1Publisher website ·
- SJR 2026-06
- 0.39LetPub ·
- SNIP 2026-06
- 0.36LetPub ·
- h-index
- 9LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 85OpenAlex ·
- 2-year mean citedness
- 1.82OpenAlex ·
- Self-citation rate
- 4.8%LetPub ·
- Share of gold OA articles
- 99.59%LetPub ·
Volume
- Articles per year
- 84LetPub ·
Articles by year OpenAlex count · 2,464 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 67 | 9 |
| 2025 | 98 | 98 | 89 |
| 2024 | 94 | 94 | 374 |
| 2023 | 88 | 88 | 338 |
| 2022 | 61 | 45 | 620 |
| 2021 | 47 | 46 | 245 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 1,500 | Yes | CC BY | |
| OpenAlex | EUR 1,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Tech Science Press
- Country or region
- FRANCE
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1292-3818
- Electronic ISSN
- 1765-2839
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Oncologie
What CAS zone is Oncologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Oncologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Oncologie?
The latest impact factor listed by LetPub is 2.13; CiteScore 3.1, h-index 22.
How long does peer review take at Oncologie?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Oncologie?
According to LetPub and DOAJ records, Oncologie is indexed in SCIE, Scopus and DOAJ.
Is Oncologie open access, and what is the APC?
Oncologie is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .